About Us
SCRIP Intelligence provides vital original pharmaceutical industry ideas and global signals for your career, your business and your future.
Customers receive a glimpse of the future from the daily drumbeat of crucial events across the sector spectrum – from biotech start-ups to multinational giants; research boutiques to generic manufacturers; and suppliers large and small.
Our experienced writers and analysts are based in key geographic markets to convey all aspects of the industry. Global hot topics such as orphan diseases, personalized medicine, and management strategies from developed to emerging markets are covered with local depth and insight.
SCRIP Intelligence is available in a variety of formats to suit your needs, including online, mobile, email, podcasts and video. Daily and a weekly email alerts highlight what you need to know to stay ahead of the curve.
| Editorial | |||
![]() | Christopher Bowe Chief of Content christopher.bowe@informausa.com Follow @6B +1 212 520 2701 | Christopher is the Chief of Content, Scrip Group, overseeing editorial operations of Scrip Intelligence, Clinica and Scrip Regulatory Affairs. His prior role was US Healthcare Analyst at Scrip's Ask the Analyst service. He is a recognized thought leader with key inside-outside perspectives on industry having previously served at Schering-Plough. Christopher is an award-winning writer for earlier work at the Financial Times. He also previously worked at Dow Jones Newswires and The Wall Street Journal Europe. He is a contributor to Harvard Business Review blogs, and he has made numerous appearances on major broadcast media including BBC, Bloomberg TV, CNBC, CNN. | |
![]() | John Hodgson Managing Editor john.hodgson@informa.com Follow @ScripJohn +44 203 377 3923 | John has been a commentator and participant in biotechnology and life sciences research for over three decades as a writer and consultant. His focus has been on the use of deep data of all kinds to dispel market myths and redirect efforts in early commercial decision-making. | |
| SCRIP US team | |||
![]() | Donna Young Washington Editor donna.young@informa.com Follow @ScripDonnaDc +1 301 216 2433 | Donna covers all Washington biopharma-related daily news, regulatory, legislative and legal, and writes the weekly US Capitol Capsule column. Donna has covered healthcare policies, legislation, regulations and legal news from Washington for more than a decade. She has extensive knowledge of the FDA, the NIH and other federal agencies, including the Department of Homeland Security, the US Patent & Trademark Office and the Federal Trade Commission. | |
![]() | Mandy Jackson US West Coast Editor mandy.jackson@informausa.com Follow @ScripMandy +1 212 652 2674 | Mandy focuses on financial and drug development news from small and mid-sized US companies. She co-ordinates with US companies editor Brett Chase and Washington, D.C. editor Donna Young to provide in-depth coverage of breaking financial, regulatory and clinical trial news. | |
![]() | Brett Chase US Companies Editor brett.chase@informausa.com Follow @brettchase +1 212 520 2713 | Brett is a veteran financial journalist, who covered the business of health care for more than a decade. Based in Chicago, he is a former editor and reporter for Bloomberg News' US health industry team and held newsroom leadership positions at Crain's Chicago Business and the Milwaukee Journal Sentinel. | |
| Back to top | |||
| SCRIP Asia team | |||
![]() | Ian Haydock Asia Editor ian.haydock@informa.com Follow @ScripIanHaydock +81 042 259 1134 | Ian is based in Tokyo and covers the Asian pharma markets for Scrip. He writes about a broad range of business strategy and development, policy/regulatory and R&D issues relevant to both big pharma and smaller start-up firms, and has a particular interest in regulatory convergence initiatives in Asia. Ian also provides coverage of the Australian bioventure sector, while his regular ‘Asia Beat’ column is published every two weeks and takes an analytical angle on major regional news. | |
![]() | Anju Ghangurde India Editor aghangurde@yahoo.com Follow @Scripanjug +91 982 028 8667 | Anju is responsible for reporting from India, a country that's often described as the pharmacy of the world. With close to a decade of previous experience in India's mainstream financial dailies, she writes extensive coverage on a broad range of issues including the generics versus brand name firms' play, pricing, the evolving regulatory and legal framework and company strategies. | |
![]() | Wang Fangqing Chinese Healthcare Reporter frances.wangfq@gmail.com | Wang Fangqing covers news and regulations in China, a huge, booming yet challenging market for foreign pharmaceutical companies. Previously, she has also worked with PharmAsia News and BioPharm Insight. She is based in Shanghai. | |
| Back to top | |||
| SCRIP Europe team | |||
![]() | Alexandra Shimmings Deputy Managing Editor alex.shimmings@informa.com Follow @ScripAlexS +44 207 017 6954 | Alex has 17 years' experience in writing about the pharmaceutical industry, specialising in drug development, clinical trials and data. | |
![]() | Eleanor Malone EMEA Editor eleanor.malone@informa.com Follow @ScripEleanor +44 207 017 6976 | Eleanor has been reporting and analysing pharmaceutical news since 2000, covering a full range of topics including M&A deals, financial reporting, company strategy and business development, drug successes and failures both in the clinic and on the market, policy and regulation, polemic, controversy and industry-related foresight and overview. | |
![]() | Sukaina Virji News Editor sukaina.virji@informa.com Follow @Scripsuki +44 203 377 3756 | Sukaina has been covering the pharmaceutical and biotechnology space for Scrip for more than six years, writing business, regulatory and clinical development news and analysis. Prior to working on Scrip, Suki was editor of BioVenture View newsletter and BioPeople magazine, publications which focused exclusively on the biotechnology sector, including financial and R&D news. She has a PhD in biochemistry and molecular biology from University College London. | |
| Francesca Bruce Senior Reporter francesca.bruce@informa.com Follow @ScripFrancesca +44 207 017 5397 | Francesca covers a range of policy and regulatory developments in Europe, with a focus on pricing and reimbursement and market access. In her role at Scrip she has also covered key emerging markets in Latin America, concentrating on Brazil, Mexico and Argentina. | |
![]() | Gemma Sharman Reporter gemma.sharman@informa.com Follow @ScripGemma +44 203 377 3891 | Gemma is a reporter on Scrip based in the UK. She covers a range of global news and analysis topics including people and appointments, clinical trial results, corporate financings, and marketing strategies including branding and social media. | |
![]() | Lucie Ellis Editorial Assistant lucie.ellis@informa.com Follow @LucieLEllis +44 207 017 4417 | Lucie is based in Scrip's UK office. She joined the team as an intern in 2012 after graduating from Sheffield Hallam University with a BA (hons) Degree in Journalism. As editorial assistant Lucie covers a range of global news including: people and appointments; corporate financings and M&A activities; R&D news; and digital/social media development in the industry. | |
| Back to top | |||
| Analysts | |||
![]() | Dr Peter Charlish peter.charlish@informa.com | Peter focuses on drug discovery and product development, including clinical trials, and regulatory affairs, with knowledge extending across pharma, medical devices and diagnostics. | |
![]() | Ian Schofield ian.schofield@informa.com | Ian writes on a wide range of issues affecting the pharmaceutical and biotech industry, with a focus on EU regulatory, political, legal and scientific affairs. He also covers specialist areas such as advanced therapies, paediatrics, generics, orphans, counterfeits and pandemic flu. | |
![]() | Phil Greenfield phil.greenfield@informa.com | Phil has many years of experience in editorial, market research and publishing in the pharmaceutical sector. His primary focus is science, technology and business across medtech and pharma. | |
![]() | Ashley Yeo ashley.yeo@informa.com | Ashley has a wealth experience of the medical technology and healthcare sectors, focusing on healthcare and trade policy, business and financial performance and regulatory affairs. He was editor of Clinica for nine years until April 2009. | |
| Back to top | |||
| Leadership | |||
![]() | Mike Ward Global Director of Content mike.ward@informa.com Follow @ScripMikeWard | Mike has been writing, analysing and commenting on the life sciences industry for the past 30 years. He has focused on business models, R&D strategies and how to finance innovation, and is often called upon by the industry's key stakeholders to provide thought leadership. In 2010 he was named European Mediscience Commentator of the Year. | |
![]() | Phil Jarvis Publishing Director phil.jarvis@informa.com | Phil is Publishing Director for the Scrip Group. Phil has over 12 years' experience in the world of B2B publishing covering the research-driven Crop Protection and Healthcare industries. Phil has a vision to grow the Scrip Group business through digital delivery of original, market-leading content. | |
| Back to top | |||
| Marketing & Customer Services | |||
| Paul Morkel Marketing Manager paul.morkel@informa.com | Dan Frere Retention Team Leader dan.frere@informa.com | Sinead Greaney New Subscriptions sinead.greaney@informa.com | Customer Service Team +44 (0)20 7017 4161 client.services@informa.com |
| Back to top | |||
To explore the complete range of pharma news, data and analysis that our subscribers enjoy every day, click on the button below to start your free trial.





















